Macronutrient composition and increased physical activity modulate plasma adipokines and appetite hormones during a weight loss intervention

Journal of Women's Health

Volumn 19, Issue 1, 2010, Pages 139-145

  Ata, Shymaa M ^a   Vaishnav, Ushma ^a   Puglisi, Michael ^a   Lofgren, Ingrid E ^b   Wood, Richard J ^c   Volek, Jeff S ^a   Fernandez, Maria Luz ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c SPRINGFIELD COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GHRELIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CARBOHYDRATE INTAKE; DIET; FAT INTAKE; FEMALE; HEALTH SERVICE; HUMAN; INCREASED APPETITE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERVENTION STUDY; MACRONUTRIENT; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INTAKE; REGULATORY MECHANISM; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADIPOKINES; ADULT; APPETITE REGULATION; BODY COMPOSITION; BODY MASS INDEX; CARNITINE; DIET, REDUCING; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; DOUBLE-BLIND METHOD; EXERCISE; FEMALE; GHRELIN; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LEPTIN; MIDDLE AGED; PREMENOPAUSE; VASCULAR CELL ADHESION MOLECULE-1; WEIGHT LOSS;

EID: 75749111008     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1472     Document Type: Article

References (43)

1. AritaY, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
2. Pellme F, Smith U, Funahashi T, et al. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 2003;52:1182-1186.
3. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003;115:37-41.
4. Gable DR, Hurel SJ, Humphries SE. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular diseases. Atherosclerosis 2006;188:231-244.
5. Naser KA, Gruber A, Thomson GA. The emerging of obesity and diabetes: Are we doing enough to prevent a disaster? Int J Clin Pract 2006;60:1093-1097.
6. Keller U. From obesity to diabetes. Int J Nutr Res 2006;76: 172-177.
7. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: An update. Clin Endocrinol 2006;64:355-365.
8. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-919.
9. Chandran M, Ciaraldi T, Phillips SA, Hener RR. Adiponectin: More than just another fat cell hormone? Diabetes Care 2003;26:2442-2450.
10. Ekmekci H, Ekmekci OB. The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thrombos Homeostas 2006;12:163-168.
11. Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocytederived macrophages. Circulation 2001;103:1057-1063.
12. Guzik TJ, Mangalt D, Korbut R. Adipokines-Novel link between inflammation and vascular function. J Physiol Pharmacol 2006;57:505-528.
13. Bacha F, Saad R, Gungor N, Arslania SA. Adiponectin in youth: Relationship to visceral adiposity, insulin sensitivity, and b-cell function. Diabetic Care 2004;27:547-552.
14. Iwashima Y, Katsuya T, Ishikawa K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004;43:1318-1323.
15. Monzillo LU, Hamdy O, Horton ES, et al. Effect of lifestyle modification on adiponectin levels in obese subjects with insulin resistance. Obes Res 2003;11:1048-1054. (Pubitemid 41151581)
16. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-2476.
17. Mehta S, Farmer JA. Obesity and inflammation: A new look at an old problem. Curr Atheroscler Rep 2007;9:134-138.
18. Yang R, Barouch LA. Leptin signaling and obesity: Cardiovascular consequences. Circ Res 2007;101:545-559.
19. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002; 147:173-180.
20. Koyima M, Hosoda H, Date Y, Makazato M, Matsuo H, Kangawa K. Ghrelin is a growth hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660.
21. Toshinai K, Mondal MS, Nakazato M, et al. Upregulation of ghrelin expression in the stomach upon fasting, insulininduced hypoglycemia, and leptin administration. Biochem Biophy Res Commun 2001;281:1220-1225.
22. Tschop M, Smiley D, Heiman M. Ghrelin induces adiposity in rodents. Nature 2000;407:908-913.
23. Haugaard S, Mu H, Vaag A, Madsbad S. Intramyocellular triglyceride content in man, influence of sex, obesity and glycaemic control. Eur J Endocrinol 2009 [Epub ahead of print].
24. Schenck-Gustafsson K. Risk factors for cardiovascular disease in women. Maturitas 2009 [Epub ahead of print].
25. Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circulation 2004;68:975-981.
26. Wood RJ, Fernandez ML. Carbohydrate restriction versus low glycemic index diets: Which is a better option for the treatment of insulin resistance and the metabolic syndrome? Nutr Rev 2009;67:179-183.
27. Malik VS, Hu FV. Popular weight-loss diets: From evidence to practice [Review]. Nat Clin Pract Cardiovasc Med 2007; 4:34-41.
28. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: A randomized trial. JAMA 2005;293:43-53.
29. Potier M, Darcel N, Tomé D. Protein, amino acids and the control of food intake [Review]. Curr Opin Clin Nutr Metab Care 2009;12:54-58.
30. Lofgren I, Zern T, Herron K, et al. Weight loss associated with reduced intake of carbohydrate reduces atherogenicity of LDL in premenopausal women. Metab Clin Exp 2005;54: 1133-1141.
31. Lofgren I, Herron K, West KL, et al. Weight loss favorably modifies anthropometrics and reverses the metabolic syndrome in premenopausal women. J Am Coll Nutr 2005;24:486-493.
32. Lofgren IE, Herron KL, Zern TL, et al. Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women. J Nutr 2004;134:1071-1076
33. Morgan CR, Lazarow A. Immunoassay of insulin using a two-antibody system. Proc Soc Exp Biol Med 1963; 110:29-32.
34. Haffner SM, Miettinen H, Stren MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997;120: 1087-1092.
35. Yang W-S, Lee W-J, Funahashi T, et al. Weight reduction increase plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001;86:3815-3819. (Pubitemid 32755982)
36. Shin M-J, Kim OY, Koh SJ, et al. Modest weight loss does not increase plasma adiponectin levels: Effects of weight loss of C-reactive protein and DNA damage. Nutr Res 2006;26:391-396.
37. Karbowska J, Kochan Z. Role of adiponectin in the regulation of carbohydrate and lipid metabolism. J Physiol Pharmacol 2006;57:103-113.
38. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty acids oxidation by activating AMP-activated protein kinase. Nat Med 2002;8: 1288-1295.
39. Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002;105:804-809.
40. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000;62:413-437.
41. Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflon K. Plasma acylation stimulating protein, adiponectin, leptin and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J. Clin Endocrinol Metab 2003;88:1594-1602.
42. Tschop M, Weyer C, Tataranni A, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707-709. (Pubitemid 32242624)
43. Kieffer TJ, Habener JF. The adipoinsular axis: Effects of leptin on pancreatic beta-cells. Am J Physiol Endocrinol Metab 2000;278:E1-14.